Science Library Category:

Varicella

Published: 2018
SYNOPSIS

The CDC mainly published selective studies and manipulated findings to support universal varicella vaccination and aggressively blocked the Research Analyst’s attempt to publish deleterious trends or outcomes. 

TITLE

US Universal Varicella Vaccination Program: CDC Censorship of Adverse Public Health Consequences

CITATION

Gary S. Goldman, Annals of Clinical Pathology 2018, 6(2): 1133.

SUMMARY

Research Analyst, Gary S. Goldman, reports findings that the Universal Varicella Vaccination Program alters the epidemiology of herpes zoster (shingles); and details ways in which the CDC, in collusion with the Los Angeles Department of Health Services (LADHS)—the Acute Communicable Disease Control unit—apparently manipulated data to conceal unwanted outcomes that supported an immunologically-mediated link between varicella and herpes zoster (HZ) epidemiology. Trends in vaccine efficacy were masked by averaging varicella vaccine efficacy over several years instead of stratifying efficacy by year. The CDC mainly published selective studies and manipulated findings to support universal varicella vaccination and aggressively blocked the Research Analyst’s attempt to publish deleterious trends or outcomes.

View Abstract

TAGS

, ,

Published: 2012
SYNOPSIS

Incidences of Chicken Pox are decreasing Shingles are increasing and the costs associated with the increase in Shingles incidences have exceed the cost savings from the decrease in Chicken Pox cases.

TITLE

Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data

CITATION

G.S. Goldman and P.G. King Vaccine, 31 (2013) 1680–1694.

SUMMARY

In 2000, varicella incidence dramatically declined to 70% of the prevaccine rate but reports of Herpes zoster, Shingles, significantly increased among adults aged 20–69 years from 2000 to 2001. Even children with a prior history of varicella demonstrated Shingles rates similar to adults. By 2002, the efficacy of the varicella vaccination had declined well below 80% and the costs of the increased shingles rate have exceeded the cost savings from varicella-disease reductions.

View Abstract

TAGS